Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy
Not yet recruitingOBSERVATIONAL
Enrollment
55
Participants
Timeline
Start Date
October 1, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
December 31, 2026
Conditions
Cervical CancerHuman Papilloma Virus (HPV)
Trial Locations (1)
32610
University of Florida, Gainesville
All Listed Sponsors
collaborator
Florida Department of Health
OTHER_GOV
lead
University of Florida
OTHER
NCT07214584 - Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy | Biotech Hunter | Biotech Hunter